Table 7.

Characteristics of 14 locally advanced patients without resection

No	Age (years)	Gender	Factor of unresectability	Chemo-therapy	Radio-therapy	Reason of death	Survival (status)
1)	50’s	M	Vascular (PV and HA)**	GS	50.4Gy	Local tumor growth	92.0 m (Dead)
2)	80’s	M	Biliary* + Vascular (PV and HA)**	GS	36Gy	Other disease	14.7 m (Dead)
3)	80’s	F	Biliary* + Vascular (HA)**	–	–	Local tumor growth	3.1 m (Dead)
4)	70’s	M	Biliary* + Vascular (HA)**	GS	–	Dissemination Liver metastasis	13.9 m (Dead)
5)	70’s	M	Vascular (HA)**	GS	–	Local tumor growth Liver metastasis	21.6 m (Dead)
6)	60’s	M	Biliary* + Vascular (HA)**	GS → GC	–	Local tumor growth Lung metastasis	18.5 m (Dead)
7)	60’s	M	Biliary*	GS	–	Local tumor growth Dissemination	18.3 m (Dead)
8)	70’s	M	Biliary*	GS → GC	36Gy	Local tumor growth, Dissemination	16.7 m (Dead)
9)	70’s	M	Vascular (HA)**	–	–	Local tumor growth, Dissemination	10.9 m (Dead)
10)	60’s	F	Biliary*	GS → GC	–	Local tumor growth Liver and bone metastasis	16.7 m (Dead)
11)	40’s	F	Vascular (PV and HA)**	GS → GC	–	Local tumor growth Distant LN metastasis	17.2 m (Dead)
12)	50’s	M	Vascular (PV and HA)**	G → GC	45Gy	Dissemination Lung and bone metastasis	24.0 m (Dead)
13)	70’s	M	Vascular (HA)**	GS → GC	–	–	18.0 m (Alive)
14)	80’s	M	Vascular (HA)**	GS	–	–	5.1 m (Alive)

*Biliary factor: biliary margin negative could not be obtained by either side of right or left trisectionectomy

**Vascular factor: Unreconstructible HA and/or PV due to tumor involvement or occlusion

G gemcitabine, GS gemcitabine + TS-1, GC gemcitabine + cisplatin